

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | bone trabecula formation (GO:0060346) | 7.02897074 |
| 2 | collagen fibril organization (GO:0030199) | 6.51022739 |
| 3 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 6.32912652 |
| 4 | regulation of apoptotic cell clearance (GO:2000425) | 6.09195356 |
| 5 | complement activation, alternative pathway (GO:0006957) | 5.98587091 |
| 6 | protein heterotrimerization (GO:0070208) | 5.40108877 |
| 7 | extracellular matrix assembly (GO:0085029) | 5.32491591 |
| 8 | muscle filament sliding (GO:0030049) | 5.19636732 |
| 9 | actin-myosin filament sliding (GO:0033275) | 5.19636732 |
| 10 | cell migration involved in heart development (GO:0060973) | 5.14365145 |
| 11 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 5.11425638 |
| 12 | mesenchymal-epithelial cell signaling (GO:0060638) | 5.03320923 |
| 13 | cardiac myofibril assembly (GO:0055003) | 4.92640078 |
| 14 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.91179995 |
| 15 | negative regulation of chondrocyte differentiation (GO:0032331) | 4.90167499 |
| 16 | skin morphogenesis (GO:0043589) | 4.86874342 |
| 17 | type B pancreatic cell proliferation (GO:0044342) | 4.86585503 |
| 18 | extracellular fibril organization (GO:0043206) | 4.86334593 |
| 19 | opsonization (GO:0008228) | 4.79348677 |
| 20 | sequestering of extracellular ligand from receptor (GO:0035581) | 4.43528354 |
| 21 | ATP synthesis coupled proton transport (GO:0015986) | 4.41048161 |
| 22 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.41048161 |
| 23 | actin-mediated cell contraction (GO:0070252) | 4.38393689 |
| 24 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.37851661 |
| 25 | dermatan sulfate biosynthetic process (GO:0030208) | 4.37505757 |
| 26 | pericardium development (GO:0060039) | 4.26972922 |
| 27 | keratan sulfate catabolic process (GO:0042340) | 4.25365047 |
| 28 | cardiac muscle contraction (GO:0060048) | 4.21656280 |
| 29 | lung vasculature development (GO:0060426) | 4.20313375 |
| 30 | blood vessel maturation (GO:0001955) | 4.19178339 |
| 31 | dermatan sulfate metabolic process (GO:0030205) | 4.16744628 |
| 32 | regulation of complement activation (GO:0030449) | 4.15957200 |
| 33 | metanephric mesenchyme development (GO:0072075) | 4.12133185 |
| 34 | * cardiac muscle tissue morphogenesis (GO:0055008) | 4.11998912 |
| 35 | regulation of protein activation cascade (GO:2000257) | 4.09019468 |
| 36 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.99254705 |
| 37 | negative regulation of cartilage development (GO:0061037) | 3.95813646 |
| 38 | lung lobe morphogenesis (GO:0060463) | 3.95690263 |
| 39 | tooth mineralization (GO:0034505) | 3.93513364 |
| 40 | kidney mesenchyme development (GO:0072074) | 3.91877084 |
| 41 | fibril organization (GO:0097435) | 3.91301881 |
| 42 | cardiac muscle hypertrophy (GO:0003300) | 3.89771791 |
| 43 | regulation of cardioblast differentiation (GO:0051890) | 3.88496460 |
| 44 | lipoxygenase pathway (GO:0019372) | 3.87516250 |
| 45 | myofibril assembly (GO:0030239) | 3.77735313 |
| 46 | collagen metabolic process (GO:0032963) | 3.75246375 |
| 47 | * muscle tissue morphogenesis (GO:0060415) | 3.71300137 |
| 48 | heart process (GO:0003015) | 3.69707989 |
| 49 | heart contraction (GO:0060047) | 3.69707989 |
| 50 | outflow tract septum morphogenesis (GO:0003148) | 3.68712510 |
| 51 | striated muscle hypertrophy (GO:0014897) | 3.67801417 |
| 52 | extracellular matrix disassembly (GO:0022617) | 3.62803981 |
| 53 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 3.61180697 |
| 54 | complement activation (GO:0006956) | 3.59561668 |
| 55 | regulation of integrin activation (GO:0033623) | 3.59206693 |
| 56 | adhesion of symbiont to host cell (GO:0044650) | 3.58105073 |
| 57 | virion attachment to host cell (GO:0019062) | 3.58105073 |
| 58 | collagen catabolic process (GO:0030574) | 3.57726750 |
| 59 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.56122731 |
| 60 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 3.55409129 |
| 61 | chondroitin sulfate catabolic process (GO:0030207) | 3.54412590 |
| 62 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.54098793 |
| 63 | muscle hypertrophy (GO:0014896) | 3.53845497 |
| 64 | protein carboxylation (GO:0018214) | 3.51910421 |
| 65 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.51910421 |
| 66 | regulation of cardiac muscle cell differentiation (GO:2000725) | 3.51609564 |
| 67 | sarcomere organization (GO:0045214) | 3.50218826 |
| 68 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.48919084 |
| 69 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.48791421 |
| 70 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.48742109 |
| 71 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.39814674 |
| 72 | glomerular basement membrane development (GO:0032836) | 3.39154045 |
| 73 | regulation of cardiac muscle hypertrophy (GO:0010611) | 3.37951212 |
| 74 | apoptotic cell clearance (GO:0043277) | 3.35892596 |
| 75 | smooth muscle tissue development (GO:0048745) | 3.35385884 |
| 76 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.35031633 |
| 77 | branching involved in prostate gland morphogenesis (GO:0060442) | 3.34262177 |
| 78 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.33834971 |
| 79 | multicellular organismal metabolic process (GO:0044236) | 3.33401235 |
| 80 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.31340419 |
| 81 | multicellular organismal catabolic process (GO:0044243) | 3.26765109 |
| 82 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.24750379 |
| 83 | actin filament-based movement (GO:0030048) | 3.23613025 |
| 84 | regulation of muscle hypertrophy (GO:0014743) | 3.23473246 |
| 85 | trabecula formation (GO:0060343) | 3.21597129 |
| 86 | * positive regulation of cardiac muscle tissue development (GO:0055025) | 3.21479416 |
| 87 | extracellular matrix organization (GO:0030198) | 3.19106776 |
| 88 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.18504261 |
| 89 | extracellular structure organization (GO:0043062) | 3.17943903 |
| 90 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.16388366 |
| 91 | endothelial cell chemotaxis (GO:0035767) | 3.12814914 |
| 92 | endocardial cushion development (GO:0003197) | 3.12424978 |
| 93 | regulation of insulin-like growth factor receptor signaling pathway (GO:0043567) | 3.12376935 |
| 94 | endodermal cell differentiation (GO:0035987) | 3.12174170 |
| 95 | cell proliferation involved in metanephros development (GO:0072203) | 3.11987068 |
| 96 | protein localization to cell surface (GO:0034394) | 3.10802732 |
| 97 | peptide cross-linking (GO:0018149) | 3.07393209 |
| 98 | striated muscle contraction (GO:0006941) | 3.00354898 |
| 99 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.99331108 |
| 100 | respiratory electron transport chain (GO:0022904) | 2.98879567 |
| 101 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.98557950 |
| 102 | chondrocyte development (GO:0002063) | 2.98554674 |
| 103 | basement membrane organization (GO:0071711) | 2.98110629 |
| 104 | middle ear morphogenesis (GO:0042474) | 2.95516529 |
| 105 | negative regulation of BMP signaling pathway (GO:0030514) | 2.95515005 |
| 106 | embryonic cranial skeleton morphogenesis (GO:0048701) | 2.94917686 |
| 107 | negative regulation of complement activation (GO:0045916) | 2.93558169 |
| 108 | adhesion of symbiont to host (GO:0044406) | 2.93073746 |
| 109 | wound healing, spreading of epidermal cells (GO:0035313) | 2.92871047 |
| 110 | cell proliferation involved in kidney development (GO:0072111) | 2.92614907 |
| 111 | complement activation, classical pathway (GO:0006958) | 2.91994769 |
| 112 | regulation of the force of heart contraction (GO:0002026) | 2.89798120 |
| 113 | electron transport chain (GO:0022900) | 2.89199064 |
| 114 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.88082673 |
| 115 | axon extension involved in axon guidance (GO:0048846) | 2.88082673 |
| 116 | negative regulation of fibrinolysis (GO:0051918) | 2.87670278 |
| 117 | cellular response to amino acid stimulus (GO:0071230) | 2.87527623 |
| 118 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.87426354 |
| 119 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.86583631 |
| 120 | negative regulation of heart growth (GO:0061117) | 2.86583631 |
| 121 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.86176282 |
| 122 | citrulline metabolic process (GO:0000052) | 2.85835354 |
| 123 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.85533901 |
| 124 | L-phenylalanine catabolic process (GO:0006559) | 2.85533901 |
| 125 | regulation of chondrocyte differentiation (GO:0032330) | 2.84858166 |
| 126 | actomyosin structure organization (GO:0031032) | 2.84716100 |
| 127 | citrulline biosynthetic process (GO:0019240) | 2.83554445 |
| 128 | ATP biosynthetic process (GO:0006754) | 2.83267131 |
| 129 | surfactant homeostasis (GO:0043129) | 2.83258687 |
| 130 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 2.82775396 |
| 131 | regulation of fibrinolysis (GO:0051917) | 2.82699809 |
| 132 | venous blood vessel morphogenesis (GO:0048845) | 2.82321523 |
| 133 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 2.82155605 |
| 134 | regulation of cartilage development (GO:0061035) | 2.81982518 |
| 135 | negative regulation of cardiac muscle tissue development (GO:0055026) | 2.79603569 |
| 136 | face morphogenesis (GO:0060325) | 2.78675911 |
| 137 | * positive regulation of cardiac muscle cell proliferation (GO:0060045) | 2.78459152 |
| 138 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.78230854 |
| 139 | protein activation cascade (GO:0072376) | 2.78147632 |
| 140 | embryonic forelimb morphogenesis (GO:0035115) | 2.77471119 |
| 141 | relaxation of smooth muscle (GO:0044557) | 2.76466332 |
| 142 | hyaluronan catabolic process (GO:0030214) | 2.76014523 |
| 143 | regulation of striated muscle cell apoptotic process (GO:0010662) | 2.75736713 |
| 144 | cell differentiation involved in metanephros development (GO:0072202) | 2.75619196 |
| 145 | * positive regulation of cardiac muscle tissue growth (GO:0055023) | 2.75122816 |
| 146 | glyoxylate metabolic process (GO:0046487) | 2.74745542 |
| 147 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.74634359 |
| 148 | negative regulation of fatty acid transport (GO:2000192) | 2.74022387 |
| 149 | regulation of humoral immune response (GO:0002920) | 2.72021954 |
| 150 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 2.71761480 |
| 151 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.71348542 |
| 152 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.71348542 |
| 153 | regulation of relaxation of muscle (GO:1901077) | 2.71140599 |
| 154 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.70779191 |
| 155 | positive regulation of fibroblast migration (GO:0010763) | 2.70058617 |
| 156 | regulation of smooth muscle cell migration (GO:0014910) | 2.69337643 |
| 157 | regulation of extracellular matrix disassembly (GO:0010715) | 2.67032716 |
| 158 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.66497260 |
| 159 | L-phenylalanine metabolic process (GO:0006558) | 2.66497260 |
| 160 | oxidative phosphorylation (GO:0006119) | 2.66442875 |
| 161 | cardiac muscle cell development (GO:0055013) | 2.66129616 |
| 162 | extracellular negative regulation of signal transduction (GO:1900116) | 2.65064189 |
| 163 | extracellular regulation of signal transduction (GO:1900115) | 2.65064189 |
| 164 | positive regulation of muscle hypertrophy (GO:0014742) | 2.64535392 |
| 165 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.64535392 |
| 166 | regulation of plasminogen activation (GO:0010755) | 2.64030643 |
| 167 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.63768539 |
| 168 | mesenchymal cell proliferation (GO:0010463) | 2.63701321 |
| 169 | arginine catabolic process (GO:0006527) | 2.60884235 |
| 170 | positive regulation of synapse maturation (GO:0090129) | 2.58327387 |
| 171 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.56808895 |
| 172 | positive regulation of response to oxidative stress (GO:1902884) | 2.56808895 |
| 173 | regulation of macrophage chemotaxis (GO:0010758) | 2.53422460 |
| 174 | mesenchyme morphogenesis (GO:0072132) | 2.51991045 |
| 175 | * positive regulation of heart growth (GO:0060421) | 2.50450660 |
| 176 | * regulation of cardiac muscle tissue development (GO:0055024) | 2.50194458 |
| 177 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.50160355 |
| 178 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.47251918 |
| 179 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.46905383 |
| 180 | cardiac cell development (GO:0055006) | 2.46365345 |
| 181 | cardiac muscle adaptation (GO:0014887) | 2.45662572 |
| 182 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.45662572 |
| 183 | muscle hypertrophy in response to stress (GO:0003299) | 2.45662572 |
| 184 | vocalization behavior (GO:0071625) | 2.44935439 |
| 185 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.42438592 |
| 186 | regulation of transcription from RNA polymerase II promoter involved in heart development (GO:190121 | 2.40650277 |
| 187 | adult heart development (GO:0007512) | 2.40302571 |
| 188 | * regulation of cardiac muscle tissue growth (GO:0055021) | 2.39011244 |
| 189 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.37679795 |
| 190 | mannose metabolic process (GO:0006013) | 2.37340786 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.78628779 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.44598464 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.19524831 |
| 4 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.19099237 |
| 5 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.08915501 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.05509236 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.90362518 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.81540536 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.76240670 |
| 10 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.69281652 |
| 11 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.61795149 |
| 12 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.51025166 |
| 13 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.48189415 |
| 14 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.44955532 |
| 15 | CJUN_26792858_Chip-Seq_BT549_Human | 2.41424931 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.40766976 |
| 17 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.33758175 |
| 18 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.30656042 |
| 19 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.29948980 |
| 20 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.23870367 |
| 21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.23146998 |
| 22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.23146998 |
| 23 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.22090358 |
| 24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.22070108 |
| 25 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.11743183 |
| 26 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.10248494 |
| 27 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.05679373 |
| 28 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.00290329 |
| 29 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.00071349 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.91940534 |
| 31 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.91564178 |
| 32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.84354906 |
| 33 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.83795822 |
| 34 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.78930735 |
| 35 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.76697758 |
| 36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.76214686 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.74959118 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.74411909 |
| 39 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.73670362 |
| 40 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.68651310 |
| 41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.66688088 |
| 42 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.64449414 |
| 43 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.63583074 |
| 44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.60972463 |
| 45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60871778 |
| 46 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.60155357 |
| 47 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.59320926 |
| 48 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.58299221 |
| 49 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.53801437 |
| 50 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.53350458 |
| 51 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.52648694 |
| 52 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.52464105 |
| 53 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.52464105 |
| 54 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.51629133 |
| 55 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.50600246 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.49908402 |
| 57 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.48784830 |
| 58 | VDR_22108803_ChIP-Seq_LS180_Human | 1.48448238 |
| 59 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46965785 |
| 60 | P300_19829295_ChIP-Seq_ESCs_Human | 1.45144201 |
| 61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43942032 |
| 62 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42324387 |
| 63 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.40838325 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.37808574 |
| 65 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36440715 |
| 66 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.35649765 |
| 67 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.34196305 |
| 68 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.34133486 |
| 69 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32679566 |
| 70 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.31102122 |
| 71 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.31085928 |
| 72 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30431958 |
| 73 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.29157987 |
| 74 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28990565 |
| 75 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.28906226 |
| 76 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.28123375 |
| 77 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.28036925 |
| 78 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.26090729 |
| 79 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.24845075 |
| 80 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.24362613 |
| 81 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.24142116 |
| 82 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.23080159 |
| 83 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.21769340 |
| 84 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.21634445 |
| 85 | TP53_16413492_ChIP-PET_HCT116_Human | 1.21082598 |
| 86 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.20838164 |
| 87 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20558595 |
| 88 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.17467885 |
| 89 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16519079 |
| 90 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.16496627 |
| 91 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.16461106 |
| 92 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.15877388 |
| 93 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.12652947 |
| 94 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.12212546 |
| 95 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11330847 |
| 96 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10966228 |
| 97 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10770705 |
| 98 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.10213204 |
| 99 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.09774827 |
| 100 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08598622 |
| 101 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08553015 |
| 102 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06027629 |
| 103 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05614218 |
| 104 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.05440785 |
| 105 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04059805 |
| 106 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03811131 |
| 107 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.02889595 |
| 108 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.02889595 |
| 109 | FUS_26573619_Chip-Seq_HEK293_Human | 1.02447616 |
| 110 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.02398008 |
| 111 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01789901 |
| 112 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.01398265 |
| 113 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.00934909 |
| 114 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.00934909 |
| 115 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00551207 |
| 116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.96296493 |
| 117 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.95910073 |
| 118 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.95323084 |
| 119 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.94723481 |
| 120 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.94039488 |
| 121 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.93826990 |
| 122 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93469081 |
| 123 | AR_19668381_ChIP-Seq_PC3_Human | 0.93157091 |
| 124 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92417663 |
| 125 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.92091404 |
| 126 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.91573675 |
| 127 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.91356661 |
| 128 | AR_25329375_ChIP-Seq_VCAP_Human | 0.91143095 |
| 129 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90809965 |
| 130 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.90496709 |
| 131 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.90367299 |
| 132 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.89967577 |
| 133 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89672418 |
| 134 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.89584417 |
| 135 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89318182 |
| 136 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.88545651 |
| 137 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.88353165 |
| 138 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88191079 |
| 139 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.88161125 |
| 140 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87632504 |
| 141 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.87069517 |
| 142 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86335896 |
| 143 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.85619129 |
| 144 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.85550976 |
| 145 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.84754457 |
| 146 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.84753263 |
| 147 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.84569917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001958_emphysema | 3.83811795 |
| 2 | MP0004510_myositis | 3.65625793 |
| 3 | MP0003122_maternal_imprinting | 3.65145382 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.33405483 |
| 5 | MP0000749_muscle_degeneration | 2.96846593 |
| 6 | MP0002736_abnormal_nociception_after | 2.86951973 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 2.86332643 |
| 8 | MP0005360_urolithiasis | 2.78220734 |
| 9 | MP0002108_abnormal_muscle_morphology | 2.76844869 |
| 10 | MP0005451_abnormal_body_composition | 2.74079304 |
| 11 | MP0001542_abnormal_bone_strength | 2.68989724 |
| 12 | MP0004084_abnormal_cardiac_muscle | 2.65525657 |
| 13 | MP0003880_abnormal_central_pattern | 2.63208983 |
| 14 | MP0005257_abnormal_intraocular_pressure | 2.45614020 |
| 15 | MP0004859_abnormal_synaptic_plasticity | 2.34873671 |
| 16 | MP0010368_abnormal_lymphatic_system | 2.34626074 |
| 17 | MP0006138_congestive_heart_failure | 2.28832155 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.26633792 |
| 19 | MP0005508_abnormal_skeleton_morphology | 2.21589282 |
| 20 | MP0004036_abnormal_muscle_relaxation | 2.17886842 |
| 21 | MP0001968_abnormal_touch/_nociception | 2.16439007 |
| 22 | MP0002972_abnormal_cardiac_muscle | 2.15308200 |
| 23 | MP0004085_abnormal_heartbeat | 2.11639379 |
| 24 | MP0002060_abnormal_skin_morphology | 2.11534222 |
| 25 | MP0002139_abnormal_hepatobiliary_system | 2.09524009 |
| 26 | MP0000516_abnormal_urinary_system | 2.02194383 |
| 27 | MP0005367_renal/urinary_system_phenotyp | 2.02194383 |
| 28 | MP0005503_abnormal_tendon_morphology | 2.01906775 |
| 29 | MP0004272_abnormal_basement_membrane | 1.94140256 |
| 30 | MP0000537_abnormal_urethra_morphology | 1.93254885 |
| 31 | MP0005085_abnormal_gallbladder_physiolo | 1.92283478 |
| 32 | MP0002127_abnormal_cardiovascular_syste | 1.89901661 |
| 33 | MP0001243_abnormal_dermal_layer | 1.83170019 |
| 34 | MP0005330_cardiomyopathy | 1.77934444 |
| 35 | MP0005620_abnormal_muscle_contractility | 1.75455628 |
| 36 | MP0003123_paternal_imprinting | 1.71668204 |
| 37 | MP0005275_abnormal_skin_tensile | 1.71017342 |
| 38 | MP0008875_abnormal_xenobiotic_pharmacok | 1.66814520 |
| 39 | MP0004484_altered_response_of | 1.63658841 |
| 40 | MP0003635_abnormal_synaptic_transmissio | 1.63639328 |
| 41 | MP0003941_abnormal_skin_development | 1.61767242 |
| 42 | MP0003121_genomic_imprinting | 1.61425525 |
| 43 | MP0004215_abnormal_myocardial_fiber | 1.57454826 |
| 44 | MP0005365_abnormal_bile_salt | 1.56998751 |
| 45 | MP0003950_abnormal_plasma_membrane | 1.52590748 |
| 46 | MP0005385_cardiovascular_system_phenoty | 1.50825007 |
| 47 | MP0001544_abnormal_cardiovascular_syste | 1.50825007 |
| 48 | MP0000751_myopathy | 1.49700910 |
| 49 | MP0004087_abnormal_muscle_fiber | 1.46621853 |
| 50 | MP0008775_abnormal_heart_ventricle | 1.45775552 |
| 51 | MP0003279_aneurysm | 1.42190574 |
| 52 | MP0009745_abnormal_behavioral_response | 1.41133899 |
| 53 | MP0002249_abnormal_larynx_morphology | 1.38804686 |
| 54 | MP0003828_pulmonary_edema | 1.35567303 |
| 55 | MP0003385_abnormal_body_wall | 1.34121444 |
| 56 | MP0002063_abnormal_learning/memory/cond | 1.33970979 |
| 57 | MP0005390_skeleton_phenotype | 1.33925902 |
| 58 | MP0009384_cardiac_valve_regurgitation | 1.33728849 |
| 59 | MP0002254_reproductive_system_inflammat | 1.33234397 |
| 60 | MP0005248_abnormal_Harderian_gland | 1.32044605 |
| 61 | MP0009053_abnormal_anal_canal | 1.31479611 |
| 62 | MP0010630_abnormal_cardiac_muscle | 1.31311185 |
| 63 | MP0004145_abnormal_muscle_electrophysio | 1.30800440 |
| 64 | MP0009780_abnormal_chondrocyte_physiolo | 1.29679446 |
| 65 | MP0004134_abnormal_chest_morphology | 1.29165603 |
| 66 | MP0003221_abnormal_cardiomyocyte_apopto | 1.28350983 |
| 67 | MP0005595_abnormal_vascular_smooth | 1.28107475 |
| 68 | MP0005332_abnormal_amino_acid | 1.27772944 |
| 69 | MP0005171_absent_coat_pigmentation | 1.26533435 |
| 70 | MP0003075_altered_response_to | 1.25925518 |
| 71 | MP0003806_abnormal_nucleotide_metabolis | 1.24640836 |
| 72 | MP0003567_abnormal_fetal_cardiomyocyte | 1.22706163 |
| 73 | MP0002735_abnormal_chemical_nociception | 1.22523719 |
| 74 | MP0003329_amyloid_beta_deposits | 1.18326597 |
| 75 | MP0000230_abnormal_systemic_arterial | 1.14992658 |
| 76 | MP0010329_abnormal_lipoprotein_level | 1.14849055 |
| 77 | MP0002064_seizures | 1.13945819 |
| 78 | MP0002896_abnormal_bone_mineralization | 1.12950385 |
| 79 | MP0002115_abnormal_skeleton_extremities | 1.12532384 |
| 80 | MP0001299_abnormal_eye_distance/ | 1.12439537 |
| 81 | MP0000534_abnormal_ureter_morphology | 1.09712505 |
| 82 | MP0003091_abnormal_cell_migration | 1.08617142 |
| 83 | MP0000163_abnormal_cartilage_morphology | 1.07131129 |
| 84 | MP0000604_amyloidosis | 1.05808517 |
| 85 | MP0004883_abnormal_blood_vessel | 1.04651844 |
| 86 | MP0000767_abnormal_smooth_muscle | 1.01492160 |
| 87 | MP0003137_abnormal_impulse_conducting | 1.00204418 |
| 88 | MP0002572_abnormal_emotion/affect_behav | 0.99314151 |
| 89 | MP0000462_abnormal_digestive_system | 0.96155438 |
| 90 | * MP0003115_abnormal_respiratory_system | 0.95586327 |
| 91 | MP0005023_abnormal_wound_healing | 0.93798450 |
| 92 | MP0001501_abnormal_sleep_pattern | 0.93393694 |
| 93 | MP0002106_abnormal_muscle_physiology | 0.92119493 |
| 94 | MP0010030_abnormal_orbit_morphology | 0.92029132 |
| 95 | MP0005623_abnormal_meninges_morphology | 0.91142558 |
| 96 | MP0000013_abnormal_adipose_tissue | 0.91024685 |
| 97 | MP0006054_spinal_hemorrhage | 0.89409801 |
| 98 | MP0002168_other_aberrant_phenotype | 0.89271384 |
| 99 | MP0001348_abnormal_lacrimal_gland | 0.88806483 |
| 100 | MP0001879_abnormal_lymphatic_vessel | 0.85992892 |
| 101 | MP0008004_abnormal_stomach_pH | 0.85232008 |
| 102 | MP0010352_gastrointestinal_tract_polyps | 0.84927737 |
| 103 | MP0002909_abnormal_adrenal_gland | 0.82868085 |
| 104 | MP0003566_abnormal_cell_adhesion | 0.81867139 |
| 105 | MP0005058_abnormal_lysosome_morphology | 0.80026757 |
| 106 | MP0003119_abnormal_digestive_system | 0.79806008 |
| 107 | MP0004233_abnormal_muscle_weight | 0.79349788 |
| 108 | MP0000733_abnormal_muscle_development | 0.78826929 |
| 109 | MP0000538_abnormal_urinary_bladder | 0.78685656 |
| 110 | MP0005369_muscle_phenotype | 0.78675810 |
| 111 | MP0001529_abnormal_vocalization | 0.78622885 |
| 112 | MP0002332_abnormal_exercise_endurance | 0.78232798 |
| 113 | MP0000428_abnormal_craniofacial_morphol | 0.76781268 |
| 114 | MP0002269_muscular_atrophy | 0.75833089 |
| 115 | MP0002295_abnormal_pulmonary_circulatio | 0.75373708 |
| 116 | MP0002932_abnormal_joint_morphology | 0.75233098 |
| 117 | MP0010386_abnormal_urinary_bladder | 0.74964058 |
| 118 | MP0000747_muscle_weakness | 0.74322879 |
| 119 | MP0002128_abnormal_blood_circulation | 0.74031124 |
| 120 | MP0000266_abnormal_heart_morphology | 0.73980864 |
| 121 | MP0002109_abnormal_limb_morphology | 0.73809816 |
| 122 | MP0001440_abnormal_grooming_behavior | 0.73770236 |
| 123 | MP0000249_abnormal_blood_vessel | 0.72667286 |
| 124 | MP0004858_abnormal_nervous_system | 0.72332989 |
| 125 | MP0005164_abnormal_response_to | 0.71882610 |
| 126 | MP0002933_joint_inflammation | 0.71393240 |
| 127 | MP0002113_abnormal_skeleton_development | 0.71002552 |
| 128 | MP0005166_decreased_susceptibility_to | 0.70551442 |
| 129 | * MP0001175_abnormal_lung_morphology | 0.70207620 |
| 130 | MP0000762_abnormal_tongue_morphology | 0.69754552 |
| 131 | * MP0002282_abnormal_trachea_morphology | 0.69626526 |
| 132 | MP0003448_altered_tumor_morphology | 0.69477612 |
| 133 | MP0003937_abnormal_limbs/digits/tail_de | 0.68605667 |
| 134 | MP0005165_increased_susceptibility_to | 0.68524156 |
| 135 | MP0000049_abnormal_middle_ear | 0.67736574 |
| 136 | MP0009250_abnormal_appendicular_skeleto | 0.67426476 |
| 137 | MP0000432_abnormal_head_morphology | 0.67356346 |
| 138 | MP0003942_abnormal_urinary_system | 0.66458820 |
| 139 | * MP0002133_abnormal_respiratory_system | 0.66199024 |
| 140 | * MP0005388_respiratory_system_phenotype | 0.66199024 |
| 141 | MP0001533_abnormal_skeleton_physiology | 0.65535532 |
| 142 | * MP0001614_abnormal_blood_vessel | 0.64835651 |
| 143 | MP0000003_abnormal_adipose_tissue | 0.62504714 |
| 144 | MP0002998_abnormal_bone_remodeling | 0.60797916 |
| 145 | MP0000759_abnormal_skeletal_muscle | 0.60131571 |
| 146 | MP0003795_abnormal_bone_structure | 0.57144642 |
| 147 | MP0001177_atelectasis | 0.56471674 |
| 148 | MP0003300_gastrointestinal_ulcer | 0.56296632 |
| 149 | MP0002114_abnormal_axial_skeleton | 0.55847937 |
| 150 | MP0005197_abnormal_uvea_morphology | 0.55330154 |
| 151 | MP0002233_abnormal_nose_morphology | 0.53191458 |
| 152 | MP0002116_abnormal_craniofacial_bone | 0.52969417 |
| 153 | MP0003935_abnormal_craniofacial_develop | 0.51230310 |
| 154 | MP0000613_abnormal_salivary_gland | 0.50591826 |
| 155 | MP0010771_integument_phenotype | 0.50475400 |
| 156 | MP0000750_abnormal_muscle_regeneration | 0.49523399 |
| 157 | MP0003045_fibrosis | 0.49328696 |
| 158 | MP0005076_abnormal_cell_differentiation | 0.47522062 |
| 159 | MP0002925_abnormal_cardiovascular_devel | 0.46174224 |
| 160 | MP0003755_abnormal_palate_morphology | 0.46019546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 7.81270700 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 6.02461506 |
| 3 | Soft skin (HP:0000977) | 5.92061124 |
| 4 | Complement deficiency (HP:0004431) | 5.01442719 |
| 5 | Atrophic scars (HP:0001075) | 4.83930251 |
| 6 | Dilatation of the ascending aorta (HP:0005111) | 4.66256530 |
| 7 | Bladder diverticulum (HP:0000015) | 4.66141388 |
| 8 | Abnormality of complement system (HP:0005339) | 4.60217685 |
| 9 | Deep venous thrombosis (HP:0002625) | 4.47170193 |
| 10 | Mitral valve prolapse (HP:0001634) | 4.20313544 |
| 11 | Fragile skin (HP:0001030) | 4.16234977 |
| 12 | Neonatal short-limb short stature (HP:0008921) | 4.05851443 |
| 13 | Follicular hyperkeratosis (HP:0007502) | 3.99542514 |
| 14 | Abnormality of dentin (HP:0010299) | 3.88824697 |
| 15 | Ankle contracture (HP:0006466) | 3.88117566 |
| 16 | Glomerulonephritis (HP:0000099) | 3.84842199 |
| 17 | Exercise-induced muscle cramps (HP:0003710) | 3.84740011 |
| 18 | Sudden death (HP:0001699) | 3.68821923 |
| 19 | Congenital malformation of the right heart (HP:0011723) | 3.66809146 |
| 20 | Double outlet right ventricle (HP:0001719) | 3.66809146 |
| 21 | Prolonged partial thromboplastin time (HP:0003645) | 3.59489969 |
| 22 | Genu recurvatum (HP:0002816) | 3.55952532 |
| 23 | Patent foramen ovale (HP:0001655) | 3.50156174 |
| 24 | Shallow orbits (HP:0000586) | 3.46370940 |
| 25 | Cerebral aneurysm (HP:0004944) | 3.45482556 |
| 26 | Wormian bones (HP:0002645) | 3.44637764 |
| 27 | Abnormal gallbladder physiology (HP:0012438) | 3.38634603 |
| 28 | Cholecystitis (HP:0001082) | 3.38634603 |
| 29 | Hyperextensible skin (HP:0000974) | 3.29998819 |
| 30 | Blue sclerae (HP:0000592) | 3.28206068 |
| 31 | Hyperventilation (HP:0002883) | 3.20616038 |
| 32 | Overgrowth (HP:0001548) | 3.20261106 |
| 33 | Bowel diverticulosis (HP:0005222) | 3.12475870 |
| 34 | Striae distensae (HP:0001065) | 3.08059381 |
| 35 | Aortic dissection (HP:0002647) | 3.06920349 |
| 36 | Protrusio acetabuli (HP:0003179) | 3.03979559 |
| 37 | Acute necrotizing encephalopathy (HP:0006965) | 3.02667063 |
| 38 | Lipoatrophy (HP:0100578) | 2.99633904 |
| 39 | Decreased circulating renin level (HP:0003351) | 2.98748786 |
| 40 | Wide anterior fontanel (HP:0000260) | 2.95969412 |
| 41 | Calf muscle hypertrophy (HP:0008981) | 2.94014602 |
| 42 | Joint laxity (HP:0001388) | 2.91893591 |
| 43 | Biconcave vertebral bodies (HP:0004586) | 2.91049594 |
| 44 | Aortic aneurysm (HP:0004942) | 2.86654795 |
| 45 | Atrial fibrillation (HP:0005110) | 2.83374692 |
| 46 | Slender build (HP:0001533) | 2.82918738 |
| 47 | Aneurysm (HP:0002617) | 2.82693153 |
| 48 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.81269302 |
| 49 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.81203672 |
| 50 | Osteolytic defects of the hand bones (HP:0009699) | 2.81203672 |
| 51 | Spinal rigidity (HP:0003306) | 2.74853453 |
| 52 | Mitral regurgitation (HP:0001653) | 2.74590898 |
| 53 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.74401181 |
| 54 | Focal motor seizures (HP:0011153) | 2.74239741 |
| 55 | Aortic regurgitation (HP:0001659) | 2.72432648 |
| 56 | Primary atrial arrhythmia (HP:0001692) | 2.68038858 |
| 57 | Acute encephalopathy (HP:0006846) | 2.64467997 |
| 58 | Abnormal delivery (HP:0001787) | 2.63702106 |
| 59 | Wrist flexion contracture (HP:0001239) | 2.63177115 |
| 60 | Hepatoblastoma (HP:0002884) | 2.57807655 |
| 61 | Coronal craniosynostosis (HP:0004440) | 2.56882094 |
| 62 | Ectopia lentis (HP:0001083) | 2.56864838 |
| 63 | Abnormality of the common coagulation pathway (HP:0010990) | 2.56567018 |
| 64 | Hypobetalipoproteinemia (HP:0003563) | 2.55354585 |
| 65 | Supraventricular tachycardia (HP:0004755) | 2.53866172 |
| 66 | Exercise-induced myalgia (HP:0003738) | 2.51482510 |
| 67 | Broad metatarsal (HP:0001783) | 2.50739101 |
| 68 | Malnutrition (HP:0004395) | 2.48889886 |
| 69 | Supraventricular arrhythmia (HP:0005115) | 2.47677229 |
| 70 | Hydroureter (HP:0000072) | 2.46606328 |
| 71 | Hypoplastic left heart (HP:0004383) | 2.45348300 |
| 72 | Elbow flexion contracture (HP:0002987) | 2.43109700 |
| 73 | Progressive macrocephaly (HP:0004481) | 2.42207872 |
| 74 | Joint stiffness (HP:0001387) | 2.41909876 |
| 75 | Hypoplasia of the iris (HP:0007676) | 2.41400966 |
| 76 | Abnormality of the acetabulum (HP:0003170) | 2.40613383 |
| 77 | J-shaped sella turcica (HP:0002680) | 2.38270013 |
| 78 | Mild short stature (HP:0003502) | 2.37925733 |
| 79 | Nephritis (HP:0000123) | 2.36757400 |
| 80 | Aortic valve stenosis (HP:0001650) | 2.35342777 |
| 81 | Camptodactyly of toe (HP:0001836) | 2.34981471 |
| 82 | Subacute progressive viral hepatitis (HP:0006572) | 2.33939678 |
| 83 | Disproportionate tall stature (HP:0001519) | 2.32699903 |
| 84 | Cerebral edema (HP:0002181) | 2.32639189 |
| 85 | Mitral stenosis (HP:0001718) | 2.32304176 |
| 86 | Increased corneal curvature (HP:0100692) | 2.32149536 |
| 87 | Keratoconus (HP:0000563) | 2.32149536 |
| 88 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.28693316 |
| 89 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.28693316 |
| 90 | Single umbilical artery (HP:0001195) | 2.28693316 |
| 91 | Thin bony cortex (HP:0002753) | 2.28492643 |
| 92 | Vertebral compression fractures (HP:0002953) | 2.27291770 |
| 93 | Syncope (HP:0001279) | 2.25929572 |
| 94 | Cervical subluxation (HP:0003308) | 2.25003206 |
| 95 | Limited hip movement (HP:0008800) | 2.24808288 |
| 96 | Morphological abnormality of the middle ear (HP:0008609) | 2.23530747 |
| 97 | Spondylolisthesis (HP:0003302) | 2.23199991 |
| 98 | Right ventricular cardiomyopathy (HP:0011663) | 2.22806419 |
| 99 | Neuroendocrine neoplasm (HP:0100634) | 2.21458978 |
| 100 | Breech presentation (HP:0001623) | 2.18145449 |
| 101 | Cerebral inclusion bodies (HP:0100314) | 2.17611540 |
| 102 | Asymmetric septal hypertrophy (HP:0001670) | 2.17534437 |
| 103 | Round ear (HP:0100830) | 2.16831421 |
| 104 | Osteoarthritis (HP:0002758) | 2.15465811 |
| 105 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.13845622 |
| 106 | Broad ribs (HP:0000885) | 2.12260490 |
| 107 | Hypoventilation (HP:0002791) | 2.11188087 |
| 108 | Deviation of the hallux (HP:0010051) | 2.10819540 |
| 109 | Infantile muscular hypotonia (HP:0008947) | 2.10689912 |
| 110 | Abnormality of the calf musculature (HP:0001430) | 2.10138281 |
| 111 | Increased variability in muscle fiber diameter (HP:0003557) | 2.09108454 |
| 112 | Abnormal pancreas size (HP:0012094) | 2.08076996 |
| 113 | Hip contracture (HP:0003273) | 2.06775277 |
| 114 | Esophageal neoplasm (HP:0100751) | 2.06214006 |
| 115 | Neoplasm of head and neck (HP:0012288) | 2.06214006 |
| 116 | Delusions (HP:0000746) | 2.05833692 |
| 117 | Increased connective tissue (HP:0009025) | 2.05236242 |
| 118 | Mitochondrial inheritance (HP:0001427) | 2.03884886 |
| 119 | Nonimmune hydrops fetalis (HP:0001790) | 2.03427465 |
| 120 | Hepatocellular carcinoma (HP:0001402) | 2.02388081 |
| 121 | Thoracolumbar scoliosis (HP:0002944) | 2.01786146 |
| 122 | Atrioventricular block (HP:0001678) | 2.01519342 |
| 123 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.00901294 |
| 124 | Knee flexion contracture (HP:0006380) | 2.00890907 |
| 125 | Peritonitis (HP:0002586) | 2.00825315 |
| 126 | Conjunctival hamartoma (HP:0100780) | 2.00484134 |
| 127 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.00396939 |
| 128 | Abnormality of urine glucose concentration (HP:0011016) | 2.00032801 |
| 129 | Glycosuria (HP:0003076) | 2.00032801 |
| 130 | Arterial tortuosity (HP:0005116) | 1.98766978 |
| 131 | Flat cornea (HP:0007720) | 1.98628673 |
| 132 | Inguinal hernia (HP:0000023) | 1.98154674 |
| 133 | Exercise intolerance (HP:0003546) | 1.97694924 |
| 134 | Rimmed vacuoles (HP:0003805) | 1.97610275 |
| 135 | Redundant skin (HP:0001582) | 1.97030076 |
| 136 | Steppage gait (HP:0003376) | 1.96769700 |
| 137 | Hallux valgus (HP:0001822) | 1.96398652 |
| 138 | Pheochromocytoma (HP:0002666) | 1.95813252 |
| 139 | Ovoid vertebral bodies (HP:0003300) | 1.94254624 |
| 140 | Renovascular hypertension (HP:0100817) | 1.91961187 |
| 141 | Venous insufficiency (HP:0005293) | 1.90361851 |
| 142 | Hyporeflexia of lower limbs (HP:0002600) | 1.89807932 |
| 143 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.88845020 |
| 144 | Venous abnormality (HP:0002624) | 1.88724147 |
| 145 | Ragged-red muscle fibers (HP:0003200) | 1.87272021 |
| 146 | Flexion contracture of toe (HP:0005830) | 1.86324252 |
| 147 | Joint contractures involving the joints of the feet (HP:0100492) | 1.86324252 |
| 148 | Mesomelia (HP:0003027) | 1.86031656 |
| 149 | Increased CSF lactate (HP:0002490) | 1.85957548 |
| 150 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.85701073 |
| 151 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.85249194 |
| 152 | Ventricular tachycardia (HP:0004756) | 1.85101503 |
| 153 | Gingival overgrowth (HP:0000212) | 1.84988345 |
| 154 | Dilated cardiomyopathy (HP:0001644) | 1.84965010 |
| 155 | Cerebral hemorrhage (HP:0001342) | 1.84945498 |
| 156 | Emphysema (HP:0002097) | 1.84210664 |
| 157 | Vascular tortuosity (HP:0004948) | 1.83662529 |
| 158 | Diastasis recti (HP:0001540) | 1.82709989 |
| 159 | Delayed cranial suture closure (HP:0000270) | 1.82389597 |
| 160 | Broad long bones (HP:0005622) | 1.81536952 |
| 161 | Increased serum pyruvate (HP:0003542) | 1.81033486 |
| 162 | Abnormality of glycolysis (HP:0004366) | 1.81033486 |
| 163 | Joint hemorrhage (HP:0005261) | 1.80718259 |
| 164 | Persistence of primary teeth (HP:0006335) | 1.80599457 |
| 165 | Protruding ear (HP:0000411) | 1.80311042 |
| 166 | Osteopenia (HP:0000938) | 1.79229803 |
| 167 | Arachnodactyly (HP:0001166) | 1.78291277 |
| 168 | Myoglobinuria (HP:0002913) | 1.77353792 |
| 169 | Xanthomatosis (HP:0000991) | 1.77305243 |
| 170 | Long toe (HP:0010511) | 1.74620110 |
| 171 | Narrow nasal bridge (HP:0000446) | 1.74118157 |
| 172 | Thin skin (HP:0000963) | 1.73960727 |
| 173 | EMG: myopathic abnormalities (HP:0003458) | 1.72779245 |
| 174 | Delayed CNS myelination (HP:0002188) | 1.72254176 |
| 175 | Pectus carinatum (HP:0000768) | 1.71870936 |
| 176 | Natal tooth (HP:0000695) | 1.71746654 |
| 177 | Neurofibrillary tangles (HP:0002185) | 1.71471483 |
| 178 | Cardiovascular calcification (HP:0011915) | 1.68936987 |
| 179 | Ventricular arrhythmia (HP:0004308) | 1.67234865 |
| 180 | Bronchomalacia (HP:0002780) | 1.66768119 |
| 181 | Hypoplastic heart (HP:0001961) | 1.65310725 |
| 182 | Atonic seizures (HP:0010819) | 1.64943373 |
| 183 | Type 1 muscle fiber predominance (HP:0003803) | 1.64569475 |
| 184 | Hypolipoproteinemia (HP:0010981) | 1.64333891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.68145082 |
| 2 | MYLK | 4.60800533 |
| 3 | PDGFRA | 4.39724794 |
| 4 | LATS1 | 3.98956819 |
| 5 | EPHA4 | 3.94708111 |
| 6 | DDR2 | 3.66099183 |
| 7 | MST1R | 3.18722637 |
| 8 | RIPK4 | 3.02020254 |
| 9 | NEK9 | 2.56121540 |
| 10 | AKT3 | 2.42884441 |
| 11 | PTK2B | 2.24519329 |
| 12 | PLK2 | 2.11641053 |
| 13 | PKN2 | 2.11568700 |
| 14 | NTRK3 | 2.11175486 |
| 15 | DAPK2 | 2.10627234 |
| 16 | LATS2 | 2.05842533 |
| 17 | PDGFRB | 2.04969708 |
| 18 | ZAK | 2.01483267 |
| 19 | MAP3K12 | 1.88556091 |
| 20 | MAP2K4 | 1.87443592 |
| 21 | STK24 | 1.81797348 |
| 22 | ARAF | 1.79104852 |
| 23 | EPHB2 | 1.76876857 |
| 24 | MAP3K4 | 1.76583179 |
| 25 | KIT | 1.70800682 |
| 26 | PIK3CA | 1.65112729 |
| 27 | MAP2K7 | 1.62311727 |
| 28 | STK38L | 1.61482061 |
| 29 | DAPK3 | 1.60444079 |
| 30 | MINK1 | 1.57048537 |
| 31 | DAPK1 | 1.54502315 |
| 32 | BMPR2 | 1.46605072 |
| 33 | KSR1 | 1.43103486 |
| 34 | PTK2 | 1.39724511 |
| 35 | PIK3CG | 1.36735029 |
| 36 | PRKD2 | 1.35966856 |
| 37 | MAP3K9 | 1.35247142 |
| 38 | MET | 1.34538768 |
| 39 | PRPF4B | 1.28328954 |
| 40 | MAP3K13 | 1.26184685 |
| 41 | PBK | 1.25557620 |
| 42 | LIMK1 | 1.24487053 |
| 43 | CASK | 1.23459608 |
| 44 | MAPK7 | 1.13193409 |
| 45 | RAF1 | 1.12062775 |
| 46 | ILK | 1.09936298 |
| 47 | RIPK1 | 0.99193595 |
| 48 | GRK5 | 0.95337329 |
| 49 | TTN | 0.92656914 |
| 50 | TRPM7 | 0.92440388 |
| 51 | KSR2 | 0.92438674 |
| 52 | NTRK1 | 0.92342603 |
| 53 | WNK1 | 0.92228250 |
| 54 | BCR | 0.91035354 |
| 55 | TESK1 | 0.90905720 |
| 56 | FGR | 0.90700395 |
| 57 | MARK2 | 0.90646619 |
| 58 | JAK1 | 0.86461163 |
| 59 | FES | 0.81609717 |
| 60 | FGFR4 | 0.81319476 |
| 61 | BCKDK | 0.80822707 |
| 62 | GRK6 | 0.80754582 |
| 63 | CAMK2A | 0.80331744 |
| 64 | RPS6KA2 | 0.79730228 |
| 65 | TYK2 | 0.79265488 |
| 66 | NME1 | 0.77958972 |
| 67 | PIM2 | 0.76613691 |
| 68 | PAK3 | 0.74879712 |
| 69 | GRK1 | 0.74130037 |
| 70 | SIK1 | 0.71084746 |
| 71 | CDC42BPA | 0.69306846 |
| 72 | DMPK | 0.68356462 |
| 73 | MTOR | 0.65710187 |
| 74 | TRIB3 | 0.63142297 |
| 75 | SIK3 | 0.62365021 |
| 76 | PRKCH | 0.62291812 |
| 77 | ABL2 | 0.60452165 |
| 78 | GRK7 | 0.60419857 |
| 79 | NLK | 0.60229496 |
| 80 | STK38 | 0.60008623 |
| 81 | CAMK2B | 0.58067253 |
| 82 | FGFR3 | 0.57119664 |
| 83 | RPS6KL1 | 0.56954561 |
| 84 | RPS6KC1 | 0.56954561 |
| 85 | GSK3A | 0.56596418 |
| 86 | PRKD1 | 0.56254356 |
| 87 | PAK4 | 0.55845076 |
| 88 | PRKCG | 0.54151413 |
| 89 | MAP3K7 | 0.53818321 |
| 90 | FLT3 | 0.53347984 |
| 91 | BRAF | 0.52957927 |
| 92 | FGFR1 | 0.52925000 |
| 93 | CAMK1 | 0.52741899 |
| 94 | PAK2 | 0.52686279 |
| 95 | RET | 0.50698244 |
| 96 | PRKCE | 0.50529281 |
| 97 | ROCK2 | 0.50069070 |
| 98 | PRKD3 | 0.49842939 |
| 99 | ERN1 | 0.48915256 |
| 100 | MAP2K1 | 0.47931942 |
| 101 | TGFBR2 | 0.47084286 |
| 102 | ABL1 | 0.46629185 |
| 103 | ROCK1 | 0.45214951 |
| 104 | PRKG1 | 0.44824183 |
| 105 | FYN | 0.44675059 |
| 106 | RPS6KA6 | 0.44316337 |
| 107 | BMX | 0.43853577 |
| 108 | EPHA3 | 0.42272397 |
| 109 | TGFBR1 | 0.41839461 |
| 110 | MAP3K6 | 0.41283558 |
| 111 | ADRBK2 | 0.41227043 |
| 112 | CAMK2G | 0.39726969 |
| 113 | CDK5 | 0.39573773 |
| 114 | INSRR | 0.39081249 |
| 115 | CAMK2D | 0.38996280 |
| 116 | EPHB1 | 0.38303842 |
| 117 | EGFR | 0.37585745 |
| 118 | MAPK12 | 0.37372336 |
| 119 | PRKACA | 0.36740670 |
| 120 | INSR | 0.36557791 |
| 121 | PRKCQ | 0.36475863 |
| 122 | MELK | 0.36402521 |
| 123 | FER | 0.36137565 |
| 124 | MOS | 0.35601839 |
| 125 | ADRBK1 | 0.34735748 |
| 126 | MARK3 | 0.34685268 |
| 127 | STK3 | 0.33782428 |
| 128 | TIE1 | 0.33206023 |
| 129 | IGF1R | 0.32440113 |
| 130 | PNCK | 0.32104052 |
| 131 | MAPK4 | 0.30824584 |
| 132 | CAMKK1 | 0.30678943 |
| 133 | CDK8 | 0.30411839 |
| 134 | DYRK1A | 0.30284237 |
| 135 | STK16 | 0.30100562 |
| 136 | CAMK1G | 0.29856501 |
| 137 | PRKCZ | 0.29597488 |
| 138 | MAP3K11 | 0.29088960 |
| 139 | CDK18 | 0.28846439 |
| 140 | MAPK1 | 0.28505067 |
| 141 | ICK | 0.28012058 |
| 142 | CDK14 | 0.27845195 |
| 143 | PAK1 | 0.27783597 |
| 144 | PAK6 | 0.27726375 |
| 145 | SRC | 0.26542330 |
| 146 | MAPKAPK5 | 0.25086954 |
| 147 | PRKG2 | 0.24181291 |
| 148 | ERBB4 | 0.23831761 |
| 149 | MAPKAPK2 | 0.23575628 |
| 150 | ERBB3 | 0.22392329 |
| 151 | TAF1 | 0.20368214 |
| 152 | HIPK2 | 0.18965082 |
| 153 | SGK223 | 0.18830399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 4.84851751 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.56908922 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.49023542 |
| 4 | Protein digestion and absorption_Homo sapiens_hsa04974 | 3.47781097 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.11745304 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.98234622 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.57219519 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.43892076 |
| 9 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 2.37338614 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.37107933 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.33368334 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.23266323 |
| 13 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 2.12485326 |
| 14 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.04925466 |
| 15 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.01713932 |
| 16 | Melanoma_Homo sapiens_hsa05218 | 1.93196990 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.86899689 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.83574668 |
| 19 | Nicotine addiction_Homo sapiens_hsa05033 | 1.79067895 |
| 20 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.70453549 |
| 21 | Adherens junction_Homo sapiens_hsa04520 | 1.69743795 |
| 22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.69004214 |
| 23 | * Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.68166167 |
| 24 | Huntingtons disease_Homo sapiens_hsa05016 | 1.63475970 |
| 25 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.60587577 |
| 26 | Circadian entrainment_Homo sapiens_hsa04713 | 1.56724164 |
| 27 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.55329935 |
| 28 | Long-term potentiation_Homo sapiens_hsa04720 | 1.52127349 |
| 29 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.48355031 |
| 30 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.47945474 |
| 31 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.47891193 |
| 32 | * Basal cell carcinoma_Homo sapiens_hsa05217 | 1.41820856 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.40384828 |
| 34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.35434719 |
| 35 | Morphine addiction_Homo sapiens_hsa05032 | 1.33804235 |
| 36 | Prostate cancer_Homo sapiens_hsa05215 | 1.32207091 |
| 37 | Olfactory transduction_Homo sapiens_hsa04740 | 1.31401544 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.28977932 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.28688045 |
| 40 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.26133250 |
| 41 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.25241421 |
| 42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.25222541 |
| 43 | * Hippo signaling pathway_Homo sapiens_hsa04390 | 1.23175897 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.22605418 |
| 45 | * Pathways in cancer_Homo sapiens_hsa05200 | 1.22264325 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.18691963 |
| 47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17583262 |
| 48 | Other glycan degradation_Homo sapiens_hsa00511 | 1.17235756 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15081491 |
| 50 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.13832798 |
| 51 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.13516426 |
| 52 | Bladder cancer_Homo sapiens_hsa05219 | 1.12200609 |
| 53 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.09741900 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09479131 |
| 55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.09397184 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08976470 |
| 57 | GABAergic synapse_Homo sapiens_hsa04727 | 1.07116379 |
| 58 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.06932816 |
| 59 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.06715186 |
| 60 | Prion diseases_Homo sapiens_hsa05020 | 1.06321852 |
| 61 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.06271911 |
| 62 | Renin secretion_Homo sapiens_hsa04924 | 1.04260085 |
| 63 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.04056563 |
| 64 | * Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.03897545 |
| 65 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.01986157 |
| 66 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.01544631 |
| 67 | Glioma_Homo sapiens_hsa05214 | 1.00453772 |
| 68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.99089545 |
| 69 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.98704322 |
| 70 | Long-term depression_Homo sapiens_hsa04730 | 0.97674266 |
| 71 | Salivary secretion_Homo sapiens_hsa04970 | 0.96794873 |
| 72 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.96529705 |
| 73 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.96394295 |
| 74 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.96002389 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.95951288 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.95127918 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.93468272 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92898749 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.92437720 |
| 80 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.91826463 |
| 81 | Gap junction_Homo sapiens_hsa04540 | 0.91337139 |
| 82 | Tight junction_Homo sapiens_hsa04530 | 0.87714604 |
| 83 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.86158810 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.85552886 |
| 85 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84573716 |
| 86 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.83621255 |
| 87 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83144684 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.82727664 |
| 89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81861413 |
| 90 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.79950507 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.79434245 |
| 92 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77155618 |
| 93 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76185281 |
| 94 | * Wnt signaling pathway_Homo sapiens_hsa04310 | 0.76164777 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.75345653 |
| 96 | Pertussis_Homo sapiens_hsa05133 | 0.75040264 |
| 97 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.74183352 |
| 98 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.73546154 |
| 99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.73155802 |
| 100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72818978 |
| 101 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.72630183 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71424134 |
| 103 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.71069927 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68990399 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68716927 |
| 106 | Amoebiasis_Homo sapiens_hsa05146 | 0.68673047 |
| 107 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.68524698 |
| 108 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.66656452 |
| 109 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.66095724 |
| 110 | Lysosome_Homo sapiens_hsa04142 | 0.65942856 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65543862 |
| 112 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65539021 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.65004251 |
| 114 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64434101 |
| 115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64001176 |
| 116 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63625896 |
| 117 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.62280568 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.62045366 |
| 119 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.61858763 |
| 120 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.60991576 |
| 121 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.60299776 |
| 122 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60269768 |
| 123 | Bile secretion_Homo sapiens_hsa04976 | 0.59974496 |
| 124 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.59790698 |
| 125 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.58920609 |
| 126 | Phagosome_Homo sapiens_hsa04145 | 0.58420242 |
| 127 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.58168285 |
| 128 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58046290 |
| 129 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57324973 |
| 130 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56693653 |
| 131 | Peroxisome_Homo sapiens_hsa04146 | 0.56518143 |
| 132 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.56507669 |
| 133 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56264825 |
| 134 | Taste transduction_Homo sapiens_hsa04742 | 0.54949785 |
| 135 | Cocaine addiction_Homo sapiens_hsa05030 | 0.54883951 |
| 136 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54379009 |
| 137 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.50902194 |
| 138 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.50821055 |
| 139 | ABC transporters_Homo sapiens_hsa02010 | 0.50632346 |
| 140 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50470397 |
| 141 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49531607 |
| 142 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48958874 |
| 143 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48286122 |
| 144 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.48058384 |
| 145 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.48005385 |
| 146 | Mineral absorption_Homo sapiens_hsa04978 | 0.46073856 |
| 147 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45265103 |
| 148 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44869331 |
| 149 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.44644411 |
| 150 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44525785 |
| 151 | Colorectal cancer_Homo sapiens_hsa05210 | 0.43226004 |
| 152 | Focal adhesion_Homo sapiens_hsa04510 | 0.42186565 |
| 153 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41830240 |
| 154 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41622598 |
| 155 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41608174 |
| 156 | Axon guidance_Homo sapiens_hsa04360 | 0.40946595 |
| 157 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.40798910 |
| 158 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.40391205 |
| 159 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40244378 |
| 160 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.40098719 |
| 161 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39706482 |
| 162 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39592583 |
| 163 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.39428650 |
| 164 | Insulin secretion_Homo sapiens_hsa04911 | 0.38652706 |
| 165 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.38529459 |
| 166 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.37200288 |
| 167 | Shigellosis_Homo sapiens_hsa05131 | 0.36646522 |
| 168 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36513459 |
| 169 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35810976 |
| 170 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34553937 |
| 171 | * Melanogenesis_Homo sapiens_hsa04916 | 0.33722553 |

